The development of a carrier system that enables the transfer of a functional exogenous gene to non-or less frequently dividing mammalian cells is essential for increasing the available options for the treatment of various diseases. The issue of whether TFL-3, a recently developed cationic liposome, can be successfully used to achieve gene expression in primary cultured rat hepatocytes was examined. The hepatocytes were transfected for 4 h with plasmid DNA (pDNA) in TFL-3 at various time points after 4-h preculture. The transfection efficiency was determined at various times posttransfection with pDNA coding for chloramphenicol acetyltransferase (CAT), luciferase, or b b-galactosidase. The amount of intranuclear pDNA present, as a consequence of the lipofection, was also quantitatively determined. Successful lipofections were observed for all pDNA tested, and the efficiencies were superior to that of commercially available LIPOFECTAMINE under our experimental conditions. The degree and rate of gene expression were dependent on incubation time prior to lipofection as well as on the density of the cells per dish, but this relationship did not hold for the amount of gene delivered to the nuclei. These results indicate that TFL-3 could be a useful vector for achieving sufficient gene expression in rat hepatocytes and suggest that the culture time prior to and following lipofection, which is related to the biological condition of the cells, may be one major factor affecting efficient gene expression in nondividing cells.
The success of gene therapy is predicated on the development of gene transfer vectors that are safe and efficacious. Viral vectors such as retroviruses, 1) adenoviruses, 2) and adeno-associated viruses 3) have been extensively investigated and clearly show superior transfection efficiencies. However, their clinical applications are limited because viral vectors have numerous problems such as immunogenecity, oncogenic effects, and the possibility of endogenous virus recombination. 4, 5) Considering these limitations, nonviral vectors such as cationic liposomes offer an attractive alternative. Nonviral vectors have been developed under the assumption that they will overcome problems associated with viral gene delivery. Cationic liposomes have been confirmed to be useful tools for gene delivery to cultured cells and for gene therapy in preclinical and clinical trials. 6, 7) The liver is an important target organ for gene therapy, because hepatocytes synthesize a wide variety of proteins, perform various posttranslational modifications, and are involved in numerous diseases, both genetically inherited and acquired. Therefore if hepatocyte-targeted gene transfer were successfully developed, it would represent an important strategy for expanding treatment options for liver diseases. 8) Nonviral vectors may be sufficient for use in in vivo or ex vivo gene therapy for liver disorders, since they have several advantages over most of the commonly used viral vectors as stated above. However, the transfection of an exogenous gene using a nonviral vector system to non-or less frequently dividing cells such as liver hepatocytes remains relatively inefficient at this time.
In dividing cells such as cancer cells that are undergoing active replication, efficient higher gene expression with nonviral vectors can generally be achieved. It is likely that the dissociation of the nuclear membrane during mitosis in actively dividing cells facilitates the transfer of an exogenous gene from the cytoplasm to the nucleus, thus increasing the efficacy of gene expression. [9] [10] [11] Therefore, in non-or less frequently dividing cells, the absence or decreased level of mitosis is generally thought to be a major reason for the lower efficiency of transgene expression with nonviral vectors. Unfortunately, our knowledge of the limiting factors preventing gene expression in non-or less frequently dividing cells such as hepatocytes is incomplete.
In earlier studies, TFL-3 composed of a newly developed cationic lipid, DC-6-14, with helper lipids dioleoylphosphatidylethanolamine (DOPE) and cholesterol (CHOL) (1 : 0.75 : 0.75 molar ratio), has been reported to show increased transfection efficiency in dividing cells in vitro, even in the presence of serum. 12, 13) However, the utility of TFL-3 in gene expression in nondividing cells remains unknown. In this study therefore, the issue of whether TFL-3 increases the efficacy of transgene expression in isolated primary cultured rat hepatocytes, a model of nondividing cells, was examined. The gene expression and amount of intranuclear plasmid DNA (pDNA) after transfection with TFL-3 were determined under various experimental conditions. The relationship between gene expression and intranuclear pDNA after lipofection is briefly discussed.
MATERIALS AND METHODS
Materials TFL-3 was a generous gift from Daiichi Pharmaceutical Co. Ltd. (Tokyo, Japan). The pGEM-T vector was purchased from Promega (WI, U.S.A.). The b-Gal staining set was purchased from Roche Diagnostics (Mannheim, Germany). Collagenase TYPE I was purchased from Funakoshi (Tokyo, Japan). Cell culture reagents were obtained from Nissui Pharmaceutical Co. Ltd. (Tokyo, Japan). LIPOFECT-AMINE was purchased from Life Technologies (MD, U.S.A.). Other reagents were of analytical grade.
Preparation of Plasmids Three types of pDNA were used in this study. A pGEM/SV2CAT was prepared as described previously. 14) This pDNA is easily prepared and shows essentially the same functional property as pSV2CAT (data not shown). The pDNA pGL3-Control containing the SV40 promoter/enhancer and encoding luciferase was purchased from Promega (WI, U.S.A.). The pDNA pCMVSlacZ encoding b-galactosidase was a generous gift from Dr. Y. Shinohara (Faculty of Pharmaceutical Sciences, The University of Tokushima).
Cell Preparation and Culture Parenchymal hepatocytes were isolated from adult male Wistar rats weighing 170-200 g (Japan SLC, Shizuoka, Japan) using the in situ perfusion method. 15) Briefly, the liver was perfused in situ through the portal vein with a 0.0125% collagenase type I solution. The liver was then carefully removed and dissected, and the cells were dispersed in cold Hank's solution through a 100-mm mesh (Cell Strainer, Becton Dickinson Labware, NJ, U.S.A.) to obtain a suspension of single cells. Parenchymal hepatocytes were separated from nonparenchymal cells by differential centrifugation at 50ϫg for 90 s and resuspended in RPMI 1640 medium supplemented with 5% heatinactivated fetal bovine serum (FBS), penicillin (100 units/ml), and streptomycin (100 mg/ml). In each preparation, the viability of the isolated cells was determined by trypan blue dye exclusion. The isolated hepatocytes were plated at a density of 1.5ϫ10 6 or 3ϫ10 6 cells in a collagen type I-coated dish (100 mm, IWAKI, Tokyo, Japan), and cultured at 37°C under a humidified 5% CO 2 atmosphere for 4 h to allow them to adhere to the dish. Dead nonadhering cells were removed when the culture medium was changed following 4-h preculture. The media was changed every 24 h or before the lipofection procedure in all experiments. The dishes were maintained under a humidified 5% CO 2 atmosphere at 37°C.
Cell Transfection (Lipofection) and Assays. Cell Transfection Cationic liposomes (TFL-3; O,OЈ-ditetradecanoyl-N-(a-trimethylammonioacetyl) diethanolamine chloride (DC-6-14)/DOPE/CHOLϭ1/0.75/0.75 mol/mol) were prepared as described previously. 12) pDNA/TFL-3 complexes were prepared at a ratio of 5 mg of pDNA to 50 nmol of cationic lipid. At various culture times following the 4 h of preculture, the complexes were gently added to 3ϫ10 6 cells at a final concentration of 1 mg plasmid/ml in RPMI 1640 medium supplemented with 5% heat-inactivated FBS, penicillin (100 units/ml), and streptomycin (100 mg/ml). After 4 h of lipofection, the cells were washed twice with RPMI 1640 medium and further incubated in fresh RPMI 1640 medium for various times (0 to 72 h) until assay, as described below.
Assays Chloramphenicol Acetyltransferase (CAT) Assay: The cells were washed twice with 5 ml of cold phosphate-buffered saline (PBS, pH 7.4), and then harvested by scraping and subsequent centrifugation (3000 rpm, 4°C, 5 min) after treatment with 3 ml of Tris-HCl buffer (40 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, pH 7.4) for 10 min at 25°C. The cell pellet was then dispersed in 150 ml of 0.25 mM Tris-HCl (pH 7.5). The cells were lysed by freezethawing (2 cycles, Ϫ80 and 37°C). The cell lysate was collected by centrifugation (12000ϫg, 4°C, 2 min). A 60-ml aliquot of the supernatant was used for the measurement of CAT activity. The activities were measured by standard procedures 16) and expressed as CAT units (pmol acetylated chloramphenicol/mg protein/h).
b b-Galactosidase Staining: After washing the cells twice with 5 ml of cold PBS (pH 7.4), the cells expressing b-galactosidase were stained with the b-gal staining set according to the manufacturer's instructions (Roche Diagnostics). Microscopic images of the stained cells were obtained using an IMT-2 instrument (OLYMPUS Optical Co., Ltd., Japan).
Luciferase Activity: The cells were washed twice with 5 ml of cold PBS (pH 7.4) and then lysed by the addition of 900 ml of cell culture lysis reagent (CCLR) buffer (Promega). The cell lysate was collected and centrifuged for 2 min at 12000ϫg to obtain clear supernatant suitable for the assay. A 20-ml aliquot of the supernatant was used to determine luciferase activity using luciferase assay reagent according to the manufacturer's recommended protocol (Promega). The protein content of the lysate was measured with the DC protein assay kit (Bio-Rad Laboratories, CA, U.S.A.), and the data are expressed as light counts/min/mg of protein.
Quantification of Plasmids Delivered to the Nucleus by Southern Blot Analysis
The amount of pDNA delivered into the nuclei following lipofection was quantitatively determined using a method recently developed in our laboratory, 14) with minor modifications. Briefly, at various time points postlipofection, the cells were washed twice with 5 ml of cold PBS, and then harvested by scraping and subsequent centrifugation (3000 rpm, 4°C, 5 min) after treatment with 3 ml of Tris-HCl buffer (40 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, pH 7.4) for 10 min at 25°C. The collected cells were suspended in 0.5 ml of lysis buffer (0.5% Nonidet P-40, 10 mM NaCl, 3 mM MgCl 2 , 10 mM Tris-HCl, pH 7.4) to dissolve the plasma membrane, and the nuclear fraction was then isolated by centrifugation at 1400ϫg for 2 min at 4°C. The resulting precipitate was used as the nuclear fraction, which was treated with BamHI (Nippon Gene, Tokyo, Japan) to prevent contamination by extranuclear pDNA.
To extract nuclear DNA (containing pDNA), proteinase K (Merck, Frankfurt, Germany) was added to the nuclear fraction to a final concentration of 0.1 mg/ml. After incubation at 37°C for 4 h, proteins were eliminated by phenol/chloroform treatment and the DNA was precipitated by the addition of ethanol. The precipitate was dissolved in TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0) and used as the DNA sample. The concentration of DNA was determined by measurement of the absorbance at 260 nm with a Shimadzu UV-1200 spectrophotometer (Shimadzu, Kyoto, Japan). The number of nuclei in the samples was calculated from the amount of genomic DNA, based on the assumption that the nucleus of a hepatocyte cell contains 6ϫ10 9 nucleotide pairs of DNA. Thus, a nucleus contains 6.6ϫ10
Ϫ6 mg of DNA because the average molecular weight of one nucleotide pair is 660.
For Southern blot analysis, aliquots of an extracted DNA sample (approximately 1-10 mg) were digested with 120 units of HindIII (Nippon Gene) at 37°C overnight and then subjected to agarose gel electrophoresis. After electrophoresis, the DNA samples were transferred to a nitrocellulose membrane. For the detection of plasmids, the 32 P-labeled DNA fragment corresponding to the open reading frame of CAT, prepared by PCR with primers RHY001 and RHY006, was prepared according to the method described elsewhere 16) and used as a probe. Southern blot hybridization was carried out using a standard protocol. 16) Briefly, membranes were prehybridized at 42°C overnight in a solution consisting of 0.01 mg/ml of salmon sperm DNA, 5ϫSSPE, 5ϫDenhardt's, 0.1% sodium dodecyl sulfate (SDS), and 50% formamide and then hybridized at 42°C overnight in the same solution containing the 32 P-labeled probe. After hybridization, the membranes were washed three times with 2ϫSSC containing 0.1% SDS at 60°C for 60 min. After washing, the membranes were exposed to the imaging plate of a bioimaging analyzer Fuji-BAS 1500. Using similar experimental conditions, the utility of TFL-3 was further examined with a different pDNA (pGL3-Control) that encodes luciferase by comparison with a commercially available cationic liposome, LIPOFECTAMINE. The luciferase activities mediated by TFL-3 were much higher (approximately 20-to 30-fold) than those mediated by LIPO-FECTAMINE under the experimental conditions used (Fig.  2) . This indicates that TFL-3 is superior to LIPOFECTA-MINE in terms of lipofection in nondividing cells. In addition, using TFL-3, gene expression in cells that underwent lipofection later (42 h) after cell preparation was much higher than those in the cells treated earlier (18 h), and gene expression gradually increased and then decreased up to 72 h postlipofection when different incubation times prior to lipofection were used.
RESULTS

Effect of Culture Time Prior to Lipofection on Gene Expression in Primary Cultured Rat Hepatocytes
In addition, a culture time-dependent increase, similar to that shown in Figs. 1 and 2 , was observed in gene expression when another pDNA (pCMVS-LacZ) encoding for b-galactosidase was transfected with the TFL-3 (data not shown). Microscopic examinations confirmed that only hepatocytes were stained blue (Fig. 3) . This suggests that liver parenchymal cells and not contaminated nonparenchymal cells or lymphocytes are responsible for the expression of the exogenous gene lipofected with TFL-3 under our experimental conditions.
Relationship between Gene Expression and Amount of pDNA Delivered into Nuclei as a Consequence of Lipofection with pDNA/TFL-3 Complexes in Primary Cultured
Rat Hepatocytes Primary cultured rat hepatocytes were subjected to lipofection with pDNA (pGEM/SV2CAT)/TFL-3 complexes for 4 h at different time points after 4-h preculture. Following 4-h lipofection, CAT activity and amount of pDNA delivered to nuclei were quantitatively determined 24 h postlipofection. As shown in Fig. 4 , CAT activity increased with culture time prior to lipofection. Higher CAT activity was observed when lipofection was carried out at 42 h after 4-h preculture, and almost no activity was observed when lipofection was carried out at primary stages (0 or 14 h after 4-h preculture). Interestingly, very similar amounts of intranuclear pDNA 26 h postlipofection were detected when the cells underwent lipofection at either 0 or 42 h after 4-h preculture, whereas the expressed CAT activity was significantly different at the two time points. This suggests that the efficacy of gene expression after lipofection is not 882 Vol. 26, No. 6
Fig. 1. Effect of Culture Time Prior to Lipofection on Gene Expression in Rat Hepatocytes
Isolated rat hepatocytes (3ϫ10 6 cells) were plated in a collagen type I-coated dish (100 mm) and incubated for 4 h (preculture). At 18 h (᭹) or 42 h (᭡) following preculture, the hepatocytes were transfected with pDNA (pGEM/SV2CAT)/TFL-3 complexes for 4 h. After removal of the complexes, the hepatocytes were further incubated for periods of up to 72 h. During incubation at the indicated time points, CAT activity (pmol of CAT/mg of total protein/h) in the hepatocytes was determined as described in the Materials and Methods section. A similar tendency was observed in three independent experiments and a typical result is shown here.
Fig. 2. Utility of TFL-3 in Gene Expression in Comparison with Commercially Available LIPOFECTAMINE in Rat Heptocytes
Isolated rat hepatocytes (3ϫ10 6 cells) were plated in a collagen type I-coated dish (100 mm) and incubated for 4 h (preculture). At 18 h (᭹, ᭺) or 42 h (᭡, ᭝) following preculture, the hepatocytes were transfected with either pDNA (pGL3-Control)/TFL-3 complexes (closed symbols) or pDNA (pGL3-Control)/LIPOFECTAMINE complexes (open symbols) for 4 h. After removal of the complexes, the hepatocytes were further incubated for up to 72 h. During incubation at the indicated time points, luciferase activity (cpm/mg of total protein) in the hepatocytes was determined as described in the Materials and Methods section. A similar tendency was observed in three independent experiments and a typical result is shown here. necessarily related to the amount of pDNA delivered to nuclei by a nonviral vector.
Effect of Density of Hepatocytes on Lipofection Efficiency The viability of hepatocytes was monitored throughout these experiments. Viability gradually decreased in a culture time-dependent manner in the presence or absence of lipofection (data not shown), although the efficiency of gene expression relatively increased (Figs. 1, 2, 4) . This leads to the assumption that the density of hepatocytes may affect in vitro lipofection efficiency. To confirm this, the isolated cells were seeded with different numbers of hepatocytes (1.5ϫ10 6 or 3ϫ10 6 ) in a collagen type I coated dish (100 mm) and incubated for 4 h. Lipofection with pDNA (pGEM/SV2CAT)/TFL-3 complexes was then carried out 42 h after preculture, after which CAT activity was determined at 4, 24, 48, and 72 h (Fig. 5) . Interestingly, greater CAT activity was detected with fewer hepatocytes. CAT activity gradually increased in a postlipofection time-dependent manner, and the degree of increase was markedly greater at low density than at high density.
DISCUSSION
Efficient exogenous gene expression was achieved using a recently developed cationic liposome, TFL-3, in primary cultured rat hepatocyes as a model of non-or less frequently dividing mammalian cells. Interestingly, the level of gene expression was dependent on the time of culture prior to lipofection, on the time of culture postlipofection, and on the density of cells in a dish. Furthermore, it was shown that the extent of gene expression was not necessarily related to the amount of pDNA delivered to nuclei.
The liver is involved in the synthesis of glucose, lipids, and proteins, including enzymes and clotting factors. It also plays a major role in detoxification through both phase I (oxi- Isolated rat hepatocytes (3ϫ10 6 cells) were plated in a collagen type I-coated dish (100 mm) and incubated for 4 h (preculture). At various time points (0, 14, 26, or 42 h) following preculture, the hepatocytes were transfected with pDNA (pGEM/SV2CAT)/ TFL-3 complexes for 4 h. After removal of the complexes, the hepatocytes were further incubated for 24 h. CAT activity (pmol of CAT/mg of total protein/h) (filled columns) and amount of intranuclear pDNA (copies/nucleus) (open columns) in the hepatocytes were determined as described in the Materials and Methods section. A similar tendency was observed in three independent experiments and a typical result is shown here. N.D., not determined.
Fig. 5. Effect of Hepatocyte Density on Efficacy of Lipofection with TFL-3
The isolated rat hepatocytes were plated in a collagen type I-coated dish (100 mm) with two different cell densities [1.5ϫ10 6 cells () or 3ϫ10 6 cells (᭜)] and incubated for 4 h (preculture). At 42 h following preculture, the hepatocytes were transfected with pDNA (pGEM/SV2CAT)/TFL-3 complexes for 4 h. After removal of the complexes, the hepatocytes were further incubated for up to 72 h. During the incubation at the indicated time points, CAT activity (pmol of CAT/mg of total protein/h) in the hepatocytes was determined as described in the Materials and Methods section. A similar tendency was observed in three independent experiments and a typical result is shown here. dation/reduction) and phase II (conjugation) mechanisms. Parenchymal cells (hepatocytes) are largely responsible for these complex functions. Among currently available therapeutic options, hepatocyte transplantation is a promising procedure that could replace liver transplantation because it would overcome the shortage of available donors and a variety of technical difficulties. [17] [18] [19] [20] [21] Therefore a combination of hepatocyte transplantation 8, 22) and hepatocyte-targeted gene transfer using TFL-3, as described in this study, leading to the efficient expression of a functional protein such as enzymes or growth factors represents an important strategy for expanding treatment options for liver diseases.
Nonviral vectors could overcome problems associated with viral gene delivery, such as immunogenecity and oncogenic effects as well as the feasibility of endogenous virus recombination. However, it is well known that nonviral gene transfer to non-or less frequently dividing cells such as primary cultured cells (neurons, keratinocytes, and hepatocytes) is relatively inefficient when compared with adenoviral gene transfer. The findings reported in this study indicate that the cationic liposome TFL-3 can successfully deliver functional active pDNA to nuclei (Fig. 4) , thus permitting efficient gene expression in primary cultured hepatocytes. The transgene activity was superior to that of the commercially available cationic liposome LIPOFECTAMINE under our experimental conditions (Fig. 2) . The successful lipofection of primary hepatocytes was achieved in the presence of 5% FBS (Figs. 1-5), suggesting that this liposomal formulation may also be effective for in vivo delivery. Similar stable transfection activity of TFL-3 in the presence of 10% fetal calf serum has been reported elsewhere. 12, 13) Hence TFL-3 appears to be a suitable nonviral vector system for successful gene expression in less frequently or nondividing mammalian cells and represents an attractive potential candidate for use in in vivo or ex vivo gene therapy. The transgene activity of TFL-3 against other nondividing cells is currently under investigation in our laboratory.
Several other researchers have demonstrated sufficient gene expression in primary cultured hepatocytes using nonviral vectors. 23, 24) However, in these approaches, an extended time period was used for lipofection (more than 18 h). 23, 24) This is probably due to the fact primary hepatocytes rarely proliferate in vitro, but do so abundantly in vivo during hepatic regeneration or after liver injury. Such a longer incubation time might increase the toxicity of cationic liposomes against the cells and consequently decrease the relative gene expression in primary hepatocytes. Our results in the present study clearly indicate that a relatively shorter incubation time (4 h) results in efficient gene expression when TFL-3 is used. This shortened incubation time might serve to minimize cationic liposome-related toxicity against donor cells and consequently increase gene expression.
For efficient gene expression in primary cultured hepatocytes, the experimental conditions used appear critical. The longer the culture time of primary hepatocytes prior to lipofection, the higher the level of gene expression (Figs. 1, 5 ). These time-course studies indicate that gene expression increases with the culture time following lipofection, although the longevity of protein activity appears to be dependent on the stability of expressed protein itself (Figs. 2, 5) . In addition, as shown in Fig. 5 , gene expression decreased with increasing cell density. This is consistent with earlier results reported by Watanabe et al. 25) These experimental observations strongly suggest that increased gene expression in nondividing cells could be achieved by optimizing the experimental conditions used for transfection, such as the time of culture prior to and following lipofection, time used for lipofection, density of cells, and type of cationic liposomes used. Further experiments to explore such optimal conditions are currently in progress.
It is generally accepted that the uptake of DNA by target cells, release from intracellular vesicles, and its transport to the nucleus where transcription takes place are limiting steps in obtaining highly efficient gene expression in vivo and in vitro gene delivery. However, the findings presented in this study indicate that gene expression is not necessarily related to the amount of intranuclear pDNA delivered by lipofection (Fig. 4) . This suggests that gene expression in nondividing cells is controlled not by the process of pDNA transport into the nucleus across the nuclear membrane but rather by the process of transcription of the delivered pDNA, although the delivery of a sufficient amount of pDNA to a nucleus to permit gene expression is a requisite. Thus for the further optimization of our gene transfer system, it will be important to have a better understanding of the influence of biological conditions on the efficiency of gene expression. An understanding of such biological conditions both in vitro and in vivo would also provide general information that will aid in developing further efficient gene delivery systems for clinical use.
